Newsbenzinga
Nasus Pharma Announces CFO Eyal Rubin To Depart September 18; Appoints Oren Elmaliach As Interim CFO
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…